Skip to main content
EOB 2024-2025
French Guiana
French Guiana
French Guiana
French Guiana
French Guiana
Capacity to advance toward elimination of malaria strengthened

In the context of efforts to advance the elimination of malaria in the wider Guiana Shield, French Guiana strengthened its capacity to reduce transmission. PAHO provided sustained virtual coordination, joint planning, and engagement through the Guiana Shield Strategic Committee, enabling strengthened cross‑border collaboration with Suriname and Brazil to address persistent transmission corridors. 

[Report Landing Page]
Outcome Indicators

  • Outcome 04. Response capacity for communicable diseases
  • Outcome 12. Risk factors for communicable diseases
  • Outcome 17. Elimination of communicable diseases
    • Outcome Indicator Baseline/Target Rating
    04.f. Number of countries and territories with capacity to conduct integrated surveillance of arbovirus cases Target 2025
    No rating
    12.b. Number of countries and territories where the entire endemic (by vector transmission) territory or territorial unit has a domestic infestation index (by the main triatomine vector species or by the substitute vector, as the case may be) of less than or equal to 1% Target 2025
    No rating
    17.c [b]. Interruption of transmission of neglected infectious diseases (NID) in countries, following WHO criteria and guidelines [Chagas Disease] Target 2025
    No rating

  • Outcome 21. Data, information, knowledge, and evidence
    • Outcome Indicator Baseline/Target Rating
    21.b. Number of countries and territories that generate, analyze, and use data and information according to health priorities, disaggregated by geopolitical and demographic strata, as appropriate to the national context Target 2025
    No rating

  • Outcome 23. Health emergencies preparedness and risk reduction
    • Outcome Indicator Baseline/Target Rating
    23.a. Number of countries and territories that meet or exceed minimum capacities to manage public health risks associated with emergencies Baseline 2019
    No rating

  • Outcome 27. Leadership and governance
    • Outcome Indicator Baseline/Target Rating
    27.a. Proportion of countries and territories where the national health authority reports satisfaction with PAHO/WHO’s leading role on global and regional health issues Target 2025
    No rating
    27.b. Number of countries and territories for which there is alignment between the national health policy, strategy, or plan and the outcomes defined in the PAHO Strategic Plan 2020-2025 Target 2025
    No rating

    4. Response capacity for communicable diseases

    Communicable diseases
    04.f. Number of countries and territories with capacity to conduct integrated surveillance of arbovirus cases
    04.f. Number of countries and territories with capacity to conduct integrated surveillance of arbovirus cases
    Target Value:
    2025
    Baseline value:
    2019
    Rating:
    Partially achieved

    12. Risk factors for communicable diseases

    Communicable diseases
    12.b. Number of countries and territories where the entire endemic (by vector transmission) territory or territorial unit has a domestic infestation index (by the main triatomine vector species or by the substitute vector, as the case may be) of less
    12.b. Number of countries and territories where the entire endemic (by vector transmission) territory or territorial unit has a domestic infestation index (by the main triatomine vector species or by the substitute vector, as the case may be) of less than or equal to 1%
    Target Value:
    2025
    Baseline value:
    2019
    Rating:
    Not achieved

    17. Elimination of communicable diseases

    Communicable diseases
    17.c [b]. Interruption of transmission of neglected infectious diseases (NID) in countries, following WHO criteria and guidelines [Chagas Disease]
    17.c [b]. Interruption of transmission of neglected infectious diseases (NID) in countries, following WHO criteria and guidelines [Chagas Disease]
    Target Value:
    2025
    Baseline value:
    2019
    Rating:
    Not achieved

    21. Data, information, knowledge, and evidence

    Information systems, evidence, and research
    21.b. Number of countries and territories that generate, analyze, and use data and information according to health priorities, disaggregated by geopolitical and demographic strata, as appropriate to the national context
    21.b. Number of countries and territories that generate, analyze, and use data and information according to health priorities, disaggregated by geopolitical and demographic strata, as appropriate to the national context
    Target Value:
    2025
    Baseline value:
    2019
    Rating:
    Partially achieved

    23. Health emergencies preparedness and risk reduction

    Health emergencies
    23.a. Number of countries and territories that meet or exceed minimum capacities to manage public health risks associated with emergencies
    23.a. Number of countries and territories that meet or exceed minimum capacities to manage public health risks associated with emergencies
    Target Value:
    2025
    Baseline value:
    2019
    Rating:
    Not achieved

    27. Leadership and governance

    Leadership, governance, and enabling functions
    27.a. Proportion of countries and territories where the national health authority reports satisfaction with PAHO/WHO’s leading role on global and regional health issues
    27.a. Proportion of countries and territories where the national health authority reports satisfaction with PAHO/WHO’s leading role on global and regional health issues
    Target Value:
    2025
    Baseline value:
    2019
    Rating:
    Partially achieved
    Leadership, governance, and enabling functions
    27.b. Number of countries and territories for which there is alignment between the national health policy, strategy, or plan and the outcomes defined in the PAHO Strategic Plan 2020-2025
    27.b. Number of countries and territories for which there is alignment between the national health policy, strategy, or plan and the outcomes defined in the PAHO Strategic Plan 2020-2025
    Target Value:
    2025
    Baseline value:
    2019
    Rating:
    Partially achieved
    Output Indicators

  • OPT 4.4 Countries and territories enabled to strengthen their political, technical, operational, and regulatory platform to reduce or eliminate malaria incidence
  • OPT 17.1 Countries and territories enabled to provide early diagnosis, treatment, case investigation, and response toward malaria elimination and prevention of reestablishment
  • OPT 17.5 The Region of the Americas maintained free of poliomyelitis
    • Output (OPT) Indicator Baseline/Target Rating
    04.4.a. Number of countries and territories that implement PAHO/WHO recommended policies and inter programmatic approaches related to malaria Target 2025
    No rating
    17.1.a. Number of countries and territories implementing PAHO/WHO-recommended interventions in active foci and areas at risk of reestablishment of malaria Target 2025
    No rating
    17.5.a. Number of countries and territories that have maintained their status as free from both wild poliovirus and circulating vaccine-derived poliovirus Baseline 2023
    No rating

  • OPT 20.2 Countries and territories enabled to adopt and implement national plans of action for strengthening the quality and coverage of vital statistics
    • Output (OPT) Indicator Baseline/Target Rating
    20.2.a. Number of countries and territories implementing an updated plan of action for strengthening the quality and coverage of vital statistics Target 2025
    No rating

    4.4 Countries and territories enabled to strengthen their political, technical, operational, and regulatory platform to reduce or eliminate malaria incidence

    Communicable diseases
    04.4.a. Number of countries and territories that implement PAHO/WHO recommended policies and inter programmatic approaches related to malaria
    04.4.a. Number of countries and territories that implement PAHO/WHO recommended policies and inter programmatic approaches related to malaria
    Baseline value
    2023
    Target Value
    2025
    Rating:
    Achieved

    17.1 Countries and territories enabled to provide early diagnosis, treatment, case investigation, and response toward malaria elimination and prevention of reestablishment

    Communicable diseases
    17.1.a. Number of countries and territories implementing PAHO/WHO-recommended interventions in active foci and areas at risk of reestablishment of malaria
    17.1.a. Number of countries and territories implementing PAHO/WHO-recommended interventions in active foci and areas at risk of reestablishment of malaria
    Baseline value
    2023
    Target Value
    2025
    Rating:
    Partially achieved

    17.5 The Region of the Americas maintained free of poliomyelitis

    Communicable diseases
    17.5.a. Number of countries and territories that have maintained their status as free from both wild poliovirus and circulating vaccine-derived poliovirus
    17.5.a. Number of countries and territories that have maintained their status as free from both wild poliovirus and circulating vaccine-derived poliovirus
    Baseline value
    2023
    Target Value
    2025
    Rating:
    Partially achieved

    20.2 Countries and territories enabled to adand implement national plans of action for strengthening the quality and coverage of vital statistics

    Information systems, evidence, and research
    20.2.a. Number of countries and territories implementing an updated plan of action for strengthening the quality and coverage of vital statistics
    20.2.a. Number of countries and territories implementing an updated plan of action for strengthening the quality and coverage of vital statistics
    Baseline value
    2023
    Target Value
    2025
    Rating:
    Not achieved